1.
|
Phase: Phase III, Phase II
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: 2003-1024, 1R01DA017073, NCT00507728
|
|
2.
|
Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 09-003598, 09-002459, 1RO1CA138417, NCT00935818
|
|
3.
|
Phase: Phase III
Type: Behavioral study, Prevention
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: Pro00013846, NCT00894166
|
|
4.
|
Phase: Phase II, Phase I
Type: Behavioral study
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: 2007p-000838, 1 R03 CA130722-01, NCT00580398
|
|
5.
|
Phase: Phase II
Type: Behavioral study, Prevention
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: I-136208, Pfizer IIR-GA30523, NCT00835900
|
|
6.
|
Phase: Phase II
Type: Behavioral study, Prevention
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-035-3, DF 07-028, NCT00683280
|
|
7.
|
Phase: No phase specified
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SRI-751, NCT00301145
|
|
8.
|
Phase: No phase specified
Type: Behavioral study, Prevention
Status: Closed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000616663, R01CA129226, BUTLER-0807-004, 0807-004, NCT00790569
|
|
9.
|
Phase: No phase specified
Type: Behavioral study, Natural history/Epidemiology, Prevention
Status: Completed
Age: 18 to 55
Sponsor: Other
Protocol IDs: 999909044, 09-DA-N044, NCT00830739
|
Mobile | Español
